A significant association was also found between lean NAFLD and several plasma proteins linked to liver injury and MetS, including afamin (AFM), insulin-like growth factor binding protein (IGFBP), gelsolin, and hepatocyte growth factor activator (HGFAC). This evidence concerns the gene HGFAC and metabolic dysfunction-associated steatotic liver disease.